Phoenix Biotech Acquisition Other Current Assets

Phoenix Biotech Acquisition (PBAX) currently reports a other current assets of $610K as of June 2026. That compares with $940K in the prior-year period — down 35.3% year over year. Use the charts on this page to explore Phoenix Biotech Acquisition's other current assets history and peer comparisons.

Phoenix Biotech Acquisition's other current assets decreased from $940K to $610K — a 35.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Phoenix Biotech Acquisition reported $610K in other current assets as of June 2026. That compares with $940K in the prior-year period — down 35.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $610K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phoenix Biotech Acquisition, and consider following PBAX for alerts when major investors trade the stock.